Ho Yeong Lim

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 6

Top Topics

Randomized Controlled Trial

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

JCO precision oncology

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Shukui Qin, Hongming Pan, Jean Frédéric Blanc, Véronique Grando, Ho Yeong Lim, Xin Ying Chang, Aurora O'Brate, Christopher Stroh, Manja Friese-Hamim, Joachim Albers, Andreas Johne, Sandrine Faivre
Activity of Tepotinib in Hepatocellular Carcinoma With High-Level MET Amplification: Preclinical and Clinical Evidence. JCO precision oncology 8 (2024)
Sojung Han, Do Young Kim, Ho Yeong Lim, Jung Hwan Yoon, Baek-Yeol Ryoo, Yujeong Kim, Kookhee Kim, Bo Yeon Kim, So Young Yi, Dong Sook Kim, Do-Yeon Cho, Jina Yu, Suhyun Kim, Joong-Won Park
Sorafenib for 9,923 Patients with Hepatocellular Carcinoma: An Analysis from National Health Insurance Claim Data in South Korea. Gut and liver (2023)
Joo-Hyun Park, Jung Yong Hong, Jay J Shen, Kyung Do Han, Joon Oh Park, Young Suk Park, Ho Yeong Lim
Increased Risk of Young-Onset Digestive Tract Cancers Among Young Adults Age 20-39 Years With Nonalcoholic Fatty Liver Disease: A Nationwide Cohort Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Jörg Trojan, Patrick Mollon, Bruno Daniele, Florence Marteau, Lidia Martín, Yuxin Li, Qing Xu, Piscaglia Fabio, Renata Zaucha, Debashis Sarker, Ho Yeong Lim, Marino Venerito
Comparative Efficacy of Cabozantinib and Ramucirumab After Sorafenib for Patients with Hepatocellular Carcinoma and Alpha-fetoprotein ≥ 400 ng/mL: A Matching-Adjusted Indirect Comparison. Advances in therapy 38 (5) (2021)
Robin Kate Kelley, Bruno Sangro, William Harris, Masafumi Ikeda, Takuji Okusaka, Yoon-Koo Kang, Shu-Kui Qin, David Wai-Meng Tai, Ho Yeong Lim, Thomas Yau, Wei Peng Yong, Ann-Lii Cheng, Antonio Gasbarrini, Silvia Damian, Jordi Bruix, Mitesh J Borad, Johanna Bendell, Tae-You Kim, Nathan Standifer, Philip He, Mallory Makowsky, Alejandra Negro, Masatoshi Kudo, Ghassan K Abou-Alfa
Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (27) (2021)
Jeong Il Yu, Su Jin Lee, Jeeyun Lee, Ho Yeong Lim, Seung-Woon Paik, Gyu Sang Yoo, Changhoon Choi, Hee Chul Park
Clinical significance of radiotherapy before and/or during nivolumab treatment in hepatocellular carcinoma. Cancer medicine 8 (16) (2019)